Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

4 Stocks To Watch: ADXS, EXEL, ITCI, VRA

Published 09/17/2015, 12:37 AM
Updated 07/09/2023, 06:31 AM

It was a good day for Wall Street on Wednesday. Many of our trades did well. Let’s take a look at some longs here and see how they’re doing.

Advaxis, Inc. (NASDAQ:ADXS) had a good day on Wednesday and a nice follow-through to the swing trade. It went across the topsline, moved through the moving average, and exploded. It had a nice pop on Tuesday, going all the way up through 20.22 and backed off to 18.32 — so a nice 2¼-point pullback. It closed up 18 cents to 19.63, on nearly two million shares. A positive inside day. It looks like it wants to go higher. Look for a run up to 21-21¾ range, eventually 25. Those are the targets going forward.

Exelixis, Inc. (NASDAQ:EXEL) was put out as a swing trade. I like the way it’s looking, up 4.06 to 37.10, or 12.3, on 10.1 million shares on Wednesday. It appears to me that the left-shoulder-head-right-shoulder is a result of the stress that’s going to take it to 8.00-9.00 eventually.

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) made a monster move on Wednesday, up a whopping 22.68 to 48.79, or 86.86%, on 13.7 million shares. This was a major breakout on positive drug news — potentially a game changer. Look for this stock to consolidate and edge a little For sure, Wednesday’s low at 42 will be support. Target is in the mid 50s.

Vera Bradley, Inc. (NASDAQ:VRA), one of our swing trades, after the big pop pulled back in a nice, orderly wedge on low volume, popped 55 cents to 13.74, or 4%, on 457,500 shares traded. The volume was not as big as I would like to have seen it. Technicals look good. It feels like it could retest 14½. The target is 16½.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Other stocks on the long side include Aceto Corp. (NASDAQ:ACET), Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), Arrowhead Research Corp. (NASDAQ:ARWR), Activision Blizzard, Inc. (NASDAQ:ATVI), Collegium Pharmaceutical, Inc. (NASDAQ:COLL), Encana Corporation (NYSE:ECA), Exelixis, Inc. (NASDAQ:EXEL), Fitbit Inc. (NYSE:FIT), Weight Watchers International, Inc. (NYSE:WTW).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.